Huvepharma International BV -- Moody's assigns first-time (P)B1 rating to Huvepharma International BV; positive outlook

London, 24 July 2014 -- Moody's Investors Service, (Moody's) has today assigned a provisional (P)B1 corporate family rating (CFR) to Huvepharma International BV (Huvepharma), a parent company of Huvepharma AD, a vertically integrated developer, manufacturer and distributor of a wide range of animal health products to livestock animals with a concentration in poultry and swine. Moody's has also assigned a provisional (P)B1 rating to the proposed EUR75 million senior secured term loan A, EUR180 million senior secured term loan B and EUR20 million senior secured revolving credit facility. The outlook on the ratings is positive. This is the first time Moody's has assigned ratings to Huvepharma.

Vollständigen Artikel bei Moodys lesen